Annual Accounts Payable
$532.00 K
-$2.91 M-84.53%
December 31, 2023
Summary
- As of February 7, 2025, ELVN annual accounts payable is $532.00 thousand, with the most recent change of -$2.91 million (-84.53%) on December 31, 2023.
- During the last 3 years, ELVN annual accounts payable has fallen by -$276.00 thousand (-34.16%).
- ELVN annual accounts payable is now -84.53% below its all-time high of $3.44 million, reached on December 31, 2022.
Performance
ELVN Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.02 M
-$64.00 K-5.91%
September 30, 2024
Summary
- As of February 7, 2025, ELVN quarterly accounts payable is $1.02 million, with the most recent change of -$64.00 thousand (-5.91%) on September 30, 2024.
- Over the past year, ELVN quarterly accounts payable has dropped by -$1.71 million (-62.63%).
- ELVN quarterly accounts payable is now -82.61% below its all-time high of $5.86 million, reached on March 31, 2023.
Performance
ELVN Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ELVN Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -84.5% | -62.6% |
| 3 y3 years | -34.2% | -82.6% |
| 5 y5 years | -34.2% | -82.6% |
ELVN Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -84.5% | at low | -82.6% | +91.5% |
| 5 y | 5-year | -84.5% | at low | -82.6% | +91.5% |
| alltime | all time | -84.5% | at low | -82.6% | +91.5% |
Enliven Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.02 M(-5.9%) |
| Jun 2024 | - | $1.08 M(-60.3%) |
| Mar 2024 | - | $2.73 M(+412.6%) |
| Dec 2023 | $532.00 K | $532.00 K(-64.4%) |
| Sep 2023 | - | $1.49 M(-47.5%) |
| Jun 2023 | - | $2.84 M(-51.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $5.86 M(+70.4%) |
| Dec 2022 | $3.44 M(+36.4%) | $3.44 M(+14.9%) |
| Sep 2022 | - | $2.99 M(+18.7%) |
| Dec 2021 | $2.52 M(+212.0%) | - |
| Dec 2021 | - | $2.52 M |
| Dec 2020 | $808.00 K | - |
FAQ
- What is Enliven Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Enliven Therapeutics?
- What is Enliven Therapeutics annual accounts payable year-on-year change?
- What is Enliven Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Enliven Therapeutics?
- What is Enliven Therapeutics quarterly accounts payable year-on-year change?
What is Enliven Therapeutics annual accounts payable?
The current annual accounts payable of ELVN is $532.00 K
What is the all time high annual accounts payable for Enliven Therapeutics?
Enliven Therapeutics all-time high annual accounts payable is $3.44 M
What is Enliven Therapeutics annual accounts payable year-on-year change?
Over the past year, ELVN annual accounts payable has changed by -$2.91 M (-84.53%)
What is Enliven Therapeutics quarterly accounts payable?
The current quarterly accounts payable of ELVN is $1.02 M
What is the all time high quarterly accounts payable for Enliven Therapeutics?
Enliven Therapeutics all-time high quarterly accounts payable is $5.86 M
What is Enliven Therapeutics quarterly accounts payable year-on-year change?
Over the past year, ELVN quarterly accounts payable has changed by -$1.71 M (-62.63%)